secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001213900-26-040030
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed agrees to acquire Acellent Technologies for 270K shares valued at $1.08M
--------------------------------------------------------------------------------

- Acquiring 100% of Acellent Technologies (Hong Kong), an AI-powered financial verification company.
- Purchase price: 270,000 shares of ADVB common stock valued at $4.00/share, total $1,080,000.
- Closing subject to completion of due diligence and receipt of regulatory approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026040030/0001213900-26-040030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026040030/ea0285086-8k_advancedbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-040030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer